For more than 50 years Martyn Pring's (right) life was dominated by an 'uncontrollable' urge to itch - and nothing doctors ...

Biosimilars are safe, effective, and well-tolerated for psoriasis treatment, providing significant cost savings for the ...

Though psoriasis affects people of all skin tones, that diversity isn’t always represented in portrayals of the condition in ...

Despite uncertainty around who will sit in The White House in January and what ramifications they may bring, the industry’s ...

At 52 weeks of follow-up, more patients on Eli Lilly’s monoclonal antibody Omvoh demonstrated histologic response, suggesting ...

Imuldosa is used for the treatment of patients with autoimmune diseases such as plaque psoriasis, psoriatic arthritis, ...

News Obese Children Are More Likely to Develop Skin Conditions Related to the Immune System. Childhood obesity can contribute to the development of common immune-mediated skin dis ...

Accord BioPharma has received FDA approval for IMULDOSA, a biosimilar to STELARA, for treating chronic inflammatory conditions like psoriasis and Crohn's disease. Scheduled for a 2025 launch, it aims ...

Imuldosa (ustekinumab-srlf) is the fifth ustekinumab biosimilar referencing Stelara to receive regulatory approval in the US.

“The heroes here tonight are not make-believe heroes from Marvel Comics, but real-life heroes who have made an impact on ...

The actress and entertainment personality partnered with Amgen to share candid glimpses of how she lives with her medical ...